Skip to content

Alphabet Inc.

Follow

13F filer, CIK 1652044, Mountain View, CA

Alphabet Inc. reported $4,015,568,781 across 26 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-08. Its ten largest share positions make up 94.04% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001652044-26-000051

Period
2026-03-31
Reported value
$4.02B
Holdings
26
Top 10 weight
94.04%
New
3
Sold out
6

Stakes and trades reported after 2026-03-31

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • WULF TERAWULF INC: 13G 41,011,803 shares, 7.6% of the class, 13G filed 2026-09-25, 0001193125-26-402852Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CMEnew+3,484,020$1.03B
PLadded+3,306,252$92.4M
PAYPnew+3,125,000$66.7M
LIFEnew+3,770,156$42.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DXCMexited-1,036,937-$68.8M
RVMDreduced-52,577-$5.11M
WGSexited-22,711-$2.95M
EXASexited-23,205-$2.36M
GLUEreduced-60,673-$998K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001652044-26-000051, largest first. % of portfolio is the value over $4,015,568,781, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CMECME GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,484,020 shares 3,484,020$1.03B25.63%newTimeline
PLPLANET LABS PBCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 31,942,641 shares; 2024Q4: 31,942,641 shares; 2025Q1: 31,942,641 shares; 2025Q2: 31,942,641 shares; 2025Q3: 31,942,641 shares; 2025Q4: 31,942,641 shares; 2026Q1: 35,248,893 shares 35,248,893$985M24.53%+3,306,252Timeline
ASTSAST SPACEMOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,943,486 shares; 2025Q2: 8,943,486 shares; 2025Q3: 8,943,486 shares; 2025Q4: 8,943,486 shares; 2026Q1: 8,943,486 shares 8,943,486$741M18.46%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,256,175 shares; 2024Q4: 4,133,277 shares; 2025Q1: 4,133,277 shares; 2025Q2: 4,133,277 shares; 2025Q3: 4,133,277 shares; 2025Q4: 3,345,102 shares; 2026Q1: 3,292,525 shares 3,292,525$320M7.97%-52,577Timeline
ARMARM HOLDINGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,960,784 shares; 2024Q4: 1,960,784 shares; 2025Q1: 1,960,784 shares; 2025Q2: 1,960,784 shares; 2025Q3: 1,960,784 shares; 2025Q4: 1,960,784 shares; 2026Q1: 1,960,784 shares 1,960,784$297M7.39%0Timeline
FRSHFRESHWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 16,206,643 shares; 2024Q4: 16,206,643 shares; 2025Q1: 16,206,643 shares; 2025Q2: 16,206,643 shares; 2025Q3: 16,206,643 shares; 2025Q4: 16,206,643 shares; 2026Q1: 16,206,643 shares 16,206,643$130M3.24%0Timeline
PATHUIPATH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,034,337 shares; 2024Q4: 7,034,337 shares; 2025Q1: 7,034,337 shares; 2025Q2: 7,034,337 shares; 2025Q3: 7,034,337 shares; 2025Q4: 7,034,337 shares; 2026Q1: 7,034,337 shares 7,034,337$78.1M1.94%0Timeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,551,102 shares; 2024Q4: 1,551,102 shares; 2025Q1: 1,551,102 shares; 2025Q2: 1,551,102 shares; 2025Q3: 1,551,102 shares; 2025Q4: 1,551,102 shares; 2026Q1: 1,551,102 shares 1,551,102$70.1M1.75%0Timeline
PAYPPAYPAY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,125,000 shares 3,125,000$66.7M1.66%newTimeline
GTLBGITLAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 9,758,333 shares; 2024Q4: 6,091,238 shares; 2025Q1: 2,724,712 shares; 2025Q2: 2,724,712 shares; 2025Q3: 2,724,712 shares; 2025Q4: 2,724,712 shares; 2026Q1: 2,724,712 shares 2,724,712$59M1.47%0Timeline
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,062,498 shares; 2024Q4: 15,062,498 shares; 2025Q1: 15,062,498 shares; 2025Q2: 15,062,498 shares; 2025Q3: 16,562,498 shares; 2025Q4: 16,562,498 shares; 2026Q1: 16,562,498 shares 16,562,498$57.6M1.44%0Timeline
LIFEETHOS TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,770,156 shares 3,770,156$42.1M1.05%newTimeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,412,471 shares; 2025Q2: 2,412,471 shares; 2025Q3: 2,412,471 shares; 2025Q4: 1,388,583 shares; 2026Q1: 1,388,583 shares 1,388,583$41.4M1.03%0Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,823,126 shares; 2025Q4: 2,823,126 shares; 2026Q1: 2,823,126 shares 2,823,126$25.3M0.63%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,568,753 shares; 2024Q4: 1,568,753 shares; 2025Q1: 1,568,753 shares; 2025Q2: 1,568,753 shares; 2025Q3: 1,568,753 shares; 2025Q4: 1,568,753 shares; 2026Q1: 1,564,173 shares 1,564,173$15.6M0.39%-4,580Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,464,015 shares; 2024Q4: 1,464,015 shares; 2025Q1: 1,464,015 shares; 2025Q2: 1,464,015 shares; 2025Q3: 1,464,015 shares; 2025Q4: 744,948 shares; 2026Q1: 684,275 shares 684,275$11.3M0.28%-60,673Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 241,264 shares; 2024Q4: 241,264 shares; 2025Q1: 241,264 shares; 2025Q2: 241,264 shares; 2025Q3: 241,264 shares; 2025Q4: 241,264 shares; 2026Q1: 241,264 shares 241,264$9.71M0.24%0Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,812,500 shares; 2024Q4: 2,812,500 shares; 2025Q1: 2,812,500 shares; 2025Q2: 2,812,500 shares; 2025Q3: 2,812,500 shares; 2025Q4: 2,812,500 shares; 2026Q1: 2,812,500 shares 2,812,500$8.1M0.2%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 321,604 shares; 2024Q4: 321,604 shares; 2025Q1: 321,604 shares; 2025Q2: 321,604 shares; 2025Q3: 321,604 shares; 2025Q4: 321,604 shares; 2026Q1: 321,604 shares 321,604$7.66M0.19%0Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 293,256 shares; 2025Q3: 293,256 shares; 2025Q4: 293,256 shares; 2026Q1: 293,256 shares 293,256$5.88M0.15%0Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 481,988 shares; 2024Q4: 481,988 shares; 2025Q1: 481,988 shares; 2025Q2: 481,988 shares; 2025Q3: 481,988 shares; 2025Q4: 481,988 shares; 2026Q1: 481,988 shares 481,988$5.53M0.14%0Timeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 215,582 shares; 2025Q4: 215,582 shares; 2026Q1: 215,582 shares 215,582$4.56M0.11%0Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 889,979 shares; 2024Q4: 889,979 shares; 2025Q1: 889,979 shares; 2025Q2: 889,979 shares; 2025Q3: 889,979 shares; 2025Q4: 889,979 shares; 2026Q1: 889,979 shares 889,979$2.08M0.05%0Timeline
HYPRHYPERFINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 898,720 shares; 2024Q4: 898,720 shares; 2025Q1: 898,720 shares; 2025Q2: 898,720 shares; 2025Q3: 898,720 shares; 2025Q4: 898,720 shares; 2026Q1: 898,720 shares 898,720$971K0.02%0Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 698,262 shares; 2024Q4: 698,262 shares; 2025Q1: 698,262 shares; 2025Q2: 698,262 shares; 2025Q3: 698,262 shares; 2025Q4: 698,262 shares; 2026Q1: 698,262 shares 698,262$964K0.02%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 915,705 shares; 2024Q4: 915,705 shares; 2025Q1: 915,705 shares; 2025Q2: 915,705 shares; 2025Q3: 915,705 shares; 2025Q4: 915,705 shares; 2026Q1: 915,705 shares 915,705$632K0.02%0Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DXCMDEXCOM INC1,036,937$68.8Mshares
WGSGENEDX HOLDINGS CORP22,711$2.95Mshares
EXASEXACT SCIENCES CORP23,205$2.36Mshares
QNCXQUINCE THERAPEUTICS INC189,122$634Kshares
FULCFULCRUM THERAPEUTICS INC14,262$161Kshares
RGENREPLIGEN CORP383$62.8Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001652044-26-000051 base2026-05-08acceptance time not in the bulk data set